Loading...
Loading...
Goldman Sachs is out with its report today on Oracle
ORCL, maintaining CL-Buy.
In its report, Goldman Sachs writes, "Oracle remains a name that we see as offering both offensive and
defensive characteristics and as such it remains a CL-Buy. At $30, Oracle shares trade at 12X our CY12 EPS estimate of $2.56. Our 12-month price target of $35 is based on an equal weighting of our DCF, P/E, and EV/sales analysis."
Shares of ORCL closed Thursday at $30.07, up 1.90% from Wednesday's close.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in